1556 related articles for article (PubMed ID: 18443954)
1. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
[TBL] [Abstract][Full Text] [Related]
2. Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Hepatogastroenterology; 2008; 55(86-87):1530-6. PubMed ID: 19102336
[TBL] [Abstract][Full Text] [Related]
3. [Expression and significance of MRP, GST-pi, Topo IIalpha, and LRP in gastric carcinoma].
Yu DQ; Yi YF
Ai Zheng; 2003 May; 22(5):496-9. PubMed ID: 12753710
[TBL] [Abstract][Full Text] [Related]
4. Expression of multidrug resistance-related markers in gastric cancer.
Fan K; Fan D; Cheng LF; Li C
Anticancer Res; 2000; 20(6C):4809-14. PubMed ID: 11205224
[TBL] [Abstract][Full Text] [Related]
5. [Expression and implication of Pgp, MRP, LRP, GST-pi, Topo II alpha in tongue squamous cell carcinoma].
Leng WD; Wang DZ; Feng G; He J
Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Feb; 22(1):23-5. PubMed ID: 15017692
[TBL] [Abstract][Full Text] [Related]
6. Multidrug resistance-associated biomarkers PGP, GST-pi, Topo-II and LRP as prognostic factors in primary ovarian carcinoma.
Lu D; Shi HC; Wang ZX; Gu XW; Zeng YJ
Br J Biomed Sci; 2011; 68(2):69-74. PubMed ID: 21706917
[TBL] [Abstract][Full Text] [Related]
7. Expression of P-gp, MRP, LRP, GST-π and TopoIIα and intrinsic resistance in human lung cancer cell lines.
Wang J; Zhang J; Zhang L; Zhao L; Fan S; Yang Z; Gao F; Kong Y; Xiao GG; Wang Q
Oncol Rep; 2011 Nov; 26(5):1081-9. PubMed ID: 21805041
[TBL] [Abstract][Full Text] [Related]
8. [Multidrug resistance and its relationship with neuroendocrine differentiation in non-small cell lung carcinoma].
Yu SP; Xiong YY; Tian SF
Zhonghua Jie He He Hu Xi Za Zhi; 2003 Mar; 26(3):165-8. PubMed ID: 12816683
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of the drug resistance markers DNA topoisomerase II alpha and glutathione S-transferase-pi in the histological compartments of Wilms' tumors.
Granzen B; Efferth T; Keller U; Beniers AJ; Mertens R; Jakse G; Füzesi L
Anticancer Res; 2001; 21(1B):771-6. PubMed ID: 11299842
[TBL] [Abstract][Full Text] [Related]
10. Expression of mutant p53 and of the multidrug resistant proteins P-glycoprotein and glutathione S-transferase-pi correlated in colorectal adenocarcinoma.
Zhang Z; Deng X; Ren X; Zhang B; Chen X; Yang J; Ding H; Sui J; Song X
Scand J Gastroenterol; 2010 Aug; 45(7-8):925-34. PubMed ID: 20377486
[TBL] [Abstract][Full Text] [Related]
11. Topoisomerase II alpha expression in squamous cell carcinomas of the head and neck.
Stathopoulos GP; Kapranos N; Manolopoulos L; Papadimitriou C; Adamopoulos G
Anticancer Res; 2000; 20(1A):177-82. PubMed ID: 10769652
[TBL] [Abstract][Full Text] [Related]
12. P-glycoprotein (PGP), and not lung resistance-related protein (LRP), is a negative prognostic factor in secondary leukemias.
Damiani D; Michieli M; Ermacora A; Candoni A; Raspadori D; Geromin A; Stocchi R; Grimaz S; Masolini P; Michelutti A; Scheper RJ; Baccarani M
Haematologica; 1998 Apr; 83(4):290-7. PubMed ID: 9592977
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of MDR1, LRP, MRP, and topoisomerase IIalpha gene mRNA transcripts before and after interferon-alpha, and correlation with the mRNA expression level of the telomerase subunits hTERT and TEP1 in five unselected human melanoma cell lines.
Miracco C; Maellaro E; Pacenti L; Del Bello B; Valentini MA; Rubegni P; Pirtoli L; Volpi C; Santopietro R; Tosi P
Int J Oncol; 2003 Jul; 23(1):213-20. PubMed ID: 12792796
[TBL] [Abstract][Full Text] [Related]
14. [Expression of P-gp, GST-pi and Topo II alpha in gastric and colorectal cancers and their clinical significance].
Chen WY; Mao WM; Zhao L; Chen GP; Shu Y; Shen YF; Zhu XH; Xia Y
Zhonghua Zhong Liu Za Zhi; 2005 Dec; 27(12):738-40. PubMed ID: 16483485
[TBL] [Abstract][Full Text] [Related]
15. Expression of multidrug resistance-related markers in primary neuroblastoma.
Lu QJ; Dong F; Zhang JH; Li XH; Ma Y; Jiang WG
Chin Med J (Engl); 2004 Sep; 117(9):1358-63. PubMed ID: 15377429
[TBL] [Abstract][Full Text] [Related]
16. The effect of TRAIL on the expression of multidrug resistant genes MDR1, LRP and GST-π in drug-resistant gastric cancer cell SGC7901/VCR.
Zhang KG; Qin CY; Wang HQ; Wang JX; Wang QM
Hepatogastroenterology; 2012; 59(120):2672-6. PubMed ID: 23178631
[TBL] [Abstract][Full Text] [Related]
17. Expression of lung resistance-related protein in transitional cell carcinoma of bladder.
Zhu Y; Kong C; Zeng Y; Sun Z; Gao H
Urology; 2004 Apr; 63(4):694-8. PubMed ID: 15072883
[TBL] [Abstract][Full Text] [Related]
18. Multidrug resistance-related phenotype and apoptosis-related protein expression in ovarian serous carcinomas.
Yakirevich E; Sabo E; Naroditsky I; Sova Y; Lavie O; Resnick MB
Gynecol Oncol; 2006 Jan; 100(1):152-9. PubMed ID: 16198399
[TBL] [Abstract][Full Text] [Related]
19. Significance of multidrug resistance gene-related proteins in the postoperative chemotherapy of gastric cancer.
Yu P; Du Y; Yang L; Fan S; Wu J; Zheng S
Int J Clin Exp Pathol; 2014; 7(11):7945-50. PubMed ID: 25550836
[TBL] [Abstract][Full Text] [Related]
20. Markers of drug resistance in relapsing colon cancer.
Lazaris AC; Kavantzas NG; Zorzos HS; Tsavaris NV; Davaris PS
J Cancer Res Clin Oncol; 2002 Feb; 128(2):114-8. PubMed ID: 11862483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
